Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

Similar documents
Prosthetic valve dysfunction: stenosis or regurgitation

Echocardiographic Evaluation of Aortic Valve Prosthesis

A Practical Approach to Prosthetic Valves

Patient/prosthesis mismatch: how to evaluate and when to act?

How to Avoid Prosthesis-Patient Mismatch

Aortic Valve Replacement Improves Outcome in Patients with Preserved Ejection Fraction: PRO!

Cases of Abnormal Prosthetic Valves

Echocardiographic Evaluation of Aortic Valve Prosthesis

Echocardiographic Evaluation of Aortic Valve Prosthesis

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Echocardiographic Evaluation of Mitral Valve Prostheses

25 different brand names >44 different models Sizes mm

Low Gradient Severe? AS

Mild paravalvular regurgitation is not an independent predictor of mortality following TAVI

TAVR: Echo Measurements Pre, Post And Intra Procedure

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Sténose aortique à Bas Débit et Bas Gradient

Echocardiographic evaluation of mitral stenosis

Paravalvular Regurgitation is a Risk Factor Following TAVI

Low Gradient AS: Multi-Imaging Modalities

Comprehensive Echo Assessment of Aortic Stenosis

Doppler echocardiography is currently the

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

CARDIOLOGY GRAND ROUNDS

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.

Valvular Heart Disease

Reverse left atrium and left ventricle remodeling after aortic valve interventions

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC

Swan Song: Echocardiography as a Pulmonary Artery Catheter? Interdepartmental Division of Critical Care Medicine

Is the Peak-to-Mean Pressure Gradient Ratio Useful for Assessment of Aortic Valve Prosthesis Obstruction? Abstract. Introduction

Quantification of Aortic Regurgitation

Management of Difficult Aortic Root, Old and New solutions

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

P = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation

Disclosures Rebecca T. Hahn, MD, FASE

Focused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

Dysfunction of transcatheter mitral valve prosthesis. Early valve degeneration or thrombosis - that is the question.

Procedural Guidance of TAVR: How to Assure it Goes Right and What to Do If It Doesn t

DISCLOSURE. Relevant Financial Relationship(s) Off Label Usage. None. None

Usually we DON T need to go beyond the gradient

TAVR Cases. Disclosures 2/17/2018. February 17, :15 3:30 PM 15 min

Diastolic Heart Function: Applying the New Guidelines Case Studies

The best in heart valve disease Aortic valve stenosis

Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis

ICE: Echo Core Lab-CRF

Organic mitral regurgitation

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Balloon mitral valvuloplasty

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

PROSTHETIC. V PROSTHETIC.V

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

Aortic stenosis with concomitant mitral regurgitation

QUANTIFICATION AND PREVENTION TECHNIQUES OF PROSTHESIS-PATIENT MISMATCH

Learn and LiveSM. ACC/AHA Pocket Guideline. Based on the ACC/AHA 2006 Guideline Revision. Management of Patients With. Valvular Heart Disease

Aortic Stenosis: LVOT Obstruction

Title of image and video article Sub-Acute Leaflet Thrombosis: A Reversible Cause of Aortic Stenosis

Indicator Mild Moderate Severe

Mixed aortic valve disease

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

3D Printing & Echocardiography

Severity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root

Successful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder

DISCLOSURE. Mitral ViV: why? Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? UW Medicine NONE.

Choose the grading of diastolic function in 82 yo woman

When Does 3D Echo Make A Difference?

Blank DISCLOSURES 1/17/2017 COMPLEX VALVE CASES CHALLENGES IN EVALUATING AND MANAGING MULTIVALVULAR HEART DISEASE ECHO HAWAII 1/23/17 NONE

Relevant Financial Relationship(s) Off Label Usage. None. None

Echo Emergencies. Outline. Michael H. Picard, MD Massachusetts General Hospital Harvard Medical School No disclosures

Critical role of multi-modality planning in Transcatheter Mitral Valve Replacement

Michigan Society of Echocardiography 30 th Year Jubilee

Questions of the webinar "Imaging in TAVI procedures" Answered by Andreas Hagendorff, Victoria Delgado and Bernard Cosyns

TAVR: Intermediate Risk Patients

A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC

Subacute left ventricular outflow tract obstruction after transapical closure of a mitral paravalvular leak in the region of the aortomitral curtain

Quantitation of Aortic Regurgitation ASCeXAM / ReASCE Review Course

Back to Basics: Common Errors In Quantitation In Everyday Practice

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Aortic Valve Stenosis: Medical Treatment, Still in the Pipeline?

Affecting the elderly Requiring new approaches. Echocardiographic Evaluation of Hemodynamic Severity. Increasing prevalence Mostly degenerative

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Valve prosthesis-patient mismatch (PPM) was first defined

SONOGRAPHER & NURSE LED VALVE CLINICS

Managing the Low Output Low Gradient Aortic Stenosis Patient

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves

HEMODYNAMIC ASSESSMENT

PVL Assessment. Is paravalvular regurgitation after TAVR still an important consideration in 2018?

Transcription:

EuroValves 2015, Nice Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis? Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE FESC Canada Research Chair in Valvular Heart Diseases Université LAVAL

Disclosure Statement - Edwards Life Science: Research grant for Echo Core Lab, transcatheter aortic and mitral valve replacement - V Wave Ltd.

Etiology of High Doppler Gradients in Prosthetic Heart Valves Prosthesis-patient mismatch i.e. too small a prosthesis in too large a patient Prosthesis dysfunction due to an acute (e.g. thrombus), subacute (e.g. endocarditis) or chronic process (e.g. pannus, calcific degeneration in bioprosthesis) Central localized high velocity jet in bileaflet prosthesis Occult mitral prosthesis regurgitation

Transvalvular Flow Pattern in Bioprosthesis vs. Mechanical Prosthesis Courtesy B. Little Zoghbi et al. J Am Soc Echocardiogr, 22:975-1014, 2009.

Zoghbi et al. J Am Soc Echocardiogr, 22:975-1014, 2009.

Gradient, EOA, and DVI for Evaluation of Aortic Prosthetic Valve Function Peak Gradient (mmhg) EOA (cm 2 ) DVI Zekry et al. J Am Coll Cardiol Img 2011;4:1161 70

Ratio of Acceleration Time to Ejection Time for Aortic Prosthetic Valve Function Criteria for PV stenosis: AT>100 ms AT/LVET>0.37 Zekry et al. J Am Coll Cardiol Img 2011;4:1161 70

Dysfunction of Bileaflet Aortic Valves: Doppler-Echo vs. Cinefluoroscopy Muratori et al. JACC Img 2013; 6:196 205

Evaluation of Leaflet Morphology & Mobility: A Cornerstone of Identification of Prosthetic Valve Dysfunction Normal Abnormal Bioprosthesis Mechanical

Evaluation of Leaflet Mobility: Usefulness of Cinefluoroscopy in Mechanical Valves Normal Abnormal

High Gradient after AVR Prosthesis-Patient Mismatch Severity? <0.65: severe Yes Step 1 Predicted Indexed EOA<0.85cm 2 /m 2? Normal reference EOA / BSA Consider Prosthesis Stenosis Yes Step 2 Abnormal leaflet morphol/ mobility DVI<0.30 (<0.25) EOA<reference EOA (Δ>0.35 cm 2 ) Gradient increased during FU EOA & DVI decreased during FU AT/ET>0.37 Cinefluoro Pibarot & Dumesnil Heart ; 98:69-78, 2012 No Consider: High Flow state / aortic regurgitation Subvalvular obstruction Technical error Localized high gradient (bileaflet valve)

Case Study : High Doppler Gradient in Aortic Valve Prosthesis 72 y.o. patient with Carbomedic # 19 aortic prosthesis (3 years) : - NYHA class II-III - Moderate diastolic dysfunction - Pulmonary arterial hypertension (systolic PA pressure: 50 mmhg) Dumesnil & Pibarot, in Book: Transesophageal Echocardiography Multimedia Manual: 361, 2005 Peak Gradient = 69 mm Hg Mean Gradient = 40 mmhg

Question no. 1 What is the cause of the high gradient in this patient? a. Valve prosthesis dysfunction (thrombus / pannus)? b. Valve prosthesis-patient mismatch? c. Central localized high velocity jet?

High Gradient after AVR BSA= 1.95 m 2 Carbomedics 19 mm Reference EOA= 1.0 cm 2 Step 1 Predicted Indexed EOA<0.85cm 2 /m 2? = 0.51 cm 2 /m 2 Severe Prosthesis- Patient Mismatch! Pibarot & Dumesnil Heart; 98:69-78, 2012 Dumesnil & Pibarot, Curr Cardiol Rev 2011

Question no. 2 Is there any intrinsic dysfunction in addition to prosthesis-patient mismatch?

Case Study : High Doppler Gradient in Aortic Valve Prosthesis 68 y.o. patient 3 Years post AVR Carbomedic # 19 Reference EOA 1.0±0.4 Measured EOA = 1.06 cm 2 Predicted Indexed EOA: 0.51 cm 2 /m 2 BSA = 1.95 m 2 Measured Indexed EOA: 0.55 cm 2 /m 2

High Gradient after AVR Prosthesis-Patient Mismatch Severity? <0.65: severe Yes Step 1 Predicted Indexed EOA<0.85cm 2 /m 2? Normal reference EOA / BSA Consider Prosthesis Dysfunction Yes Step 2 Abnormal leaflet morphol/ mobility DVI<0.30 (<0.25) EOA<reference EOA (Δ>0.35 cm 2 ) Gradient increased during FU EOA & DVI decreased during FU AT/ET>0.37 Cinefluoro No Pibarot & Dumesnil Heart ; 98:69-78, 2012 Consider: High Flow state / subvalvular obstruction Technical error Localized high gradient (bileaflet valve)

Intraoperative echo after prosthesis St. Jude Regent # 21 Suprannular (reference EOA: 2.0 cm 2 ) Stroke volume: 64 ml Heart rate: 98 bpm Peak gradient: 21 mmhg Mean gradient: 14 mmhg implantation Dumesnil & Pibarot, in Book: Transesophageal Echocardiography Multimedia Manual: 361, 2005

62 y.o. woman BSA: 1.3 m 2 Case Study #2 History of Barlow disease MVR 1 year ago with a MCRI OnX #25 mechanical valve INR within target since MVR Asymptomatic Recruited for a research project

Echocardiogram Peak Gradient = 11 mmhg Mean Gradient = 6 mmhg DVI : 2.4 Measured EOA = 1.1 cm 2

Doppler-Echo Evaluation of Mitral Prosthesis - Specifics Doppler Velocity Index: VTI mvp / VTI lvot (>2.2) EOA calculated using continuity equation as follows : EOA= SV lvot / VTI mvp (Not valid if significant aortic or mitral regurgitation) Pressure half-time not valid to calculate EOA (grossly overestimates) but may be useful for serial comparisons or if delayed (>130 msec)

Question no. 1 Is valve prosthesis-patient mismatch a consideration in this case?

High Gradient after MVR Prosthesis-Patient Mismatch Severity? <0.9: severe Yes Step 1 Predicted Indexed EOA<1.2 cm 2 /m 2? Normal reference EOA / BSA Consider Prosthesis Stenosis a/o Regurgitation Yes Step 2 Abnormal leaflet morphol/ mobility DVI>2.2 EOA<reference EOA (Δ>0.4 cm 2 ) Gradient increased during FU EOA decreased during FU Cinefluoro No Pibarot & Dumesnil Heart ; 98:69-78, 2012 Consider: High flow state Technical error Localized high gradient (bileaflet valve)

Normal Reference Values of EOAs for Mitral Prostheses Pibarot & Dumesnil Circulation, 119:1034-1048, 2009

Answer: Calculate predicted indexed EOA to exclude PPM Predicted EOA for OnX #25 2.2 cm 2 BSA = 1.30 m 2 Predicted Indexed EOA = 1.7 cm 2 /m 2 SEVERE MODERATE MILD/NONE (non significant) Indexed EOA (cm 2 /m 2 ) 0.9 1.2

Question no. 2 Should we suspect a prosthesis dysfunction?

Answer : Compare the measured EOA to the normal reference EOA Measured EOA= 1.1 cm² Reference value= 2.2 cm²!!

Question no. 3 Differential diagnosis: a- Prosthesis dysfunction in this case? b- Central high velocity jet in bileaflet mechanical prosthesis?

Answer Evaluate leaflet mobility using either TEE / fluoroscopy / CT

Leaflet Mobility by TTE

Cinefluoroscopy

Transthoracic Echocardiogram

Transesophageal Echocardiogram

Zoghbi et al. J Am Soc Echocardiogr, 22:975-1014, 2009.

High Gradient after MVR Prosthesis-Patient Mismatch Severity? <0.9: severe Yes Step 1 Predicted Indexed EOA<1.2 cm 2 /m 2? Normal reference EOA / BSA Prosthesis Stenosis & Regurgitation Yes Step 2 Abnormal leaflet morphol/ mobility DVI>2.2 EOA<reference EOA (Δ>0.4 cm 2 ) Gradient increased during FU EOA decreased during FU Cinefluoro No Pibarot & Dumesnil Heart ; 98:69-78, 2012 Consider: High flow state Technical error Localized high gradient (bileaflet valve)

YES YES YES YES Pibarot & Dumesnil, Circ 119:1034-48, 2009

3D Echo for Evaluation of Prosthetic Valve Function

Case #1 3 yr. post AVR Carbomedics 19 NYHA III Echo Gradients: 69/40 EOA: 1.1 cm 2 Severe PPM Case #2 1 yr. Post MVR OnX 25 Asymptomatic Echo Gradients: 11/6 EOA: 1.1 cm 2 Severe dysfunction: Thrombus

Key Points High gradient does not always mean prosthesis dysfunction Low gradient does not always mean normal prosthesis function Multi-parametric approach is key to appropriately differentiate normal function vs. PPM vs. dysfunction

Key Points PPM High Gradient Small indexed EOA EOA ~ normal Intermediate DVI Intermediate AT/LVET Normal leaflet morphology / mobility Dysfunction High Gradient Small indexed EOA EOA << normal Small DVI Low AT/LVET Abnormal leaflet morphology / mobility

Useful References Zoghbi et al. J Am Soc Echocardiogr, 22:975-1014, 2009 Pibarot & Dumesnil Heart 2012; 98:69-78, 2012 Zamorano JL; J Am Soc Echocardiogr 2011;24:937-65